These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9810213)

  • 1. [Pharma-clinics. Doping with erythropoietin or the misuse of therapeutic advances].
    Scheen AJ
    Rev Med Liege; 1998 Aug; 53(8):499-502. PubMed ID: 9810213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and blood doping.
    Robinson N; Giraud S; Saudan C; Baume N; Avois L; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i30-4. PubMed ID: 16799100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Point of view on doping].
    Naeije R; Pagnamenta A
    Rev Med Brux; 1999 Jun; 20(3):153-8. PubMed ID: 10429539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematocrit in elite athletes.
    Vergouwen PC; Collée T; Marx JJ
    Int J Sports Med; 1999 Nov; 20(8):538-41. PubMed ID: 10606218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biochemistry of drugs and doping methods used to enhance aerobic sport performance.
    Cooper CE
    Essays Biochem; 2008; 44():63-83. PubMed ID: 18384283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin.
    Jelkmann W
    J Endocrinol Invest; 2003 Sep; 26(9):832-7. PubMed ID: 14964434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hematocrit paradox--how does blood doping really work?
    Böning D; Maassen N; Pries A
    Int J Sports Med; 2011 Apr; 32(4):242-6. PubMed ID: 20617487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant erythropoietin and analogues: a challenge for doping control.
    Pascual JA; Belalcazar V; de Bolos C; Gutiérrez R; Llop E; Segura J
    Ther Drug Monit; 2004 Apr; 26(2):175-9. PubMed ID: 15228161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
    Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
    Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood doping : infusions, erythropoietin and artificial blood.
    Eichner ER
    Sports Med; 2007; 37(4-5):389-91. PubMed ID: 17465616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The new frontiers of blood doping].
    Lippi G; Franchini M
    Recenti Prog Med; 2002 Jan; 93(1):1-8. PubMed ID: 11850993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedures for monitoring recombinant erythropoietin and analogs in doping.
    Lamon S; Robinson N; Saugy M
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):141-54, x. PubMed ID: 20122455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood transfusions in athletes. Old dogmas, new tricks.
    Lippi G; Banfi G
    Clin Chem Lab Med; 2006; 44(12):1395-402. PubMed ID: 17163813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood doping: the flip side of transfusion and transfusion alternatives.
    Cacic DL; Hervig T; Seghatchian J
    Transfus Apher Sci; 2013 Aug; 49(1):90-4. PubMed ID: 23791798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pre-competition and altitude training on blood models used to detect erythropoietin abuse by athletes.
    Ashenden MJ; Sharpe K; Schoch C; Schumacher YO
    Haematologica; 2004 Aug; 89(8):1019-20. PubMed ID: 15339692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of alterations in total hemoglobin mass on VO 2max.
    Schmidt W; Prommer N
    Exerc Sport Sci Rev; 2010 Apr; 38(2):68-75. PubMed ID: 20335738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxygen blood transport and doping].
    Audran M; Connes P; Varlet-Marie E
    Bull Acad Natl Med; 2003; 187(9):1669-79; discussion 1680-3. PubMed ID: 15369237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood boosting today].
    Audran M; Varlet-Marie E
    Bull Acad Natl Med; 2004; 188(6):945-53. PubMed ID: 15651424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American College of Sports Medicine position stand. The use of blood doping as an ergogenic aid.
    Sawka MN; Joyner MJ; Miles DS; Robertson RJ; Spriet LL; Young AJ
    Med Sci Sports Exerc; 1996 Jun; 28(6):i-viii. PubMed ID: 8926864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose exogenous erythropoietin elicits an ergogenic effect in standardbred horses.
    McKeever KH; Agans JM; Geiser S; Lorimer PJ; Maylin GA
    Equine Vet J Suppl; 2006 Aug; (36):233-8. PubMed ID: 17402424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.